股票 › CDNA
凯德诊断 CDNA
$78.56 +$2.23 (+2.92%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $78.49 -0.09%
开盘$77.88
昨收$76.33
当日区间$75.93 – $80.55
成交量1.13M
市值$4.13B
市盈率（TTM）33.1
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$139.36M+39.3% YoY
营业利润$8.11M+3,397.6% YoY
净利润$19.29M+1,051.8% YoY
摊薄每股收益$0.35+1,066.7% YoY
自由现金流$11.10M-68.6% YoY
经营现金流$12.72M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率71.0%
营业利润率0.8%
净利率25.9%
净资产收益率33.0%
资产收益率24.0%
投入资本回报率29.7%
流动比率2.31
负债/资产比率27.1%
现金及投资$250.48M
总负债$20.32M
净现金（净负债）$230.16M
自由现金流/营收12.0%
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $139.36M | $131.95M | $117.70M | $379.81M | $108.39M |
| 营业总收入 | $139.36M | $131.95M | $117.70M | $379.81M | $108.39M |
| 营业成本 | $40.29M | $34.97M | $33.63M | $123.24M | $35.51M |
| 毛利润 | $99.08M | $96.98M | $84.07M | $256.57M | $72.87M |
| 营业费用 | $90.96M | $96.73M | $82.27M | $281.64M | $78.91M |
| 销售及管理费用 | $69.64M | $74.35M | $60.86M | $210.21M | $59.61M |
| -销售及营销费用 | $31.65M | $33.44M | $30.37M | $102.64M | $30.92M |
| -管理费用 | $37.99M | $40.91M | $30.48M | $107.57M | $28.68M |
| 研发费用 | $21.32M | $22.38M | $21.42M | $71.43M | $19.31M |
| 营业利润 | $8.11M | $257,000.00 | $1.80M | -$25.07M | -$6.04M |
| 非经营性利息净收入（支出） | $2.21M | $1.74M | $1.91M | $9.17M | $2.01M |
| 非经营性利息收入 | $2.21M | $1.74M | $1.91M | $9.17M | $2.01M |
| 其他收入（支出） | $372,000.00 | $112.53M | -$930,000.00 | -$5.19M | $264,000.00 |
| 特殊收益（费用） | $0.00 | $112.97M | -$600,000.00 | -$5.71M | $0.00 |
| -业务出售收益 | $0.00 | $112.97M | – | – | – |
| 其他非经营性收入（支出） | $372,000.00 | -$440,000.00 | -$330,000.00 | $524,000.00 | $264,000.00 |
| 税前利润 | $10.69M | $114.52M | $2.78M | -$21.08M | -$3.76M |
| 税费 | -$8.60M | $3.88M | -$32,000.00 | $271,000.00 | $345,000.00 |
| 净利润 | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| 持续经营利润 | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| 归属母公司净利润 | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| 归属普通股股东净利润 | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| 基本每股收益 | $0.37 | $2.15 | $0.05 | -$0.40 | -$0.08 |
| 摊薄每股收益 | $0.35 | $2.07 | $0.05 | -$0.40 | -$0.08 |
| -减：其他特殊支出 | – | – | $600,000.00 | $5.71M | $0.00 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $641.46M | $532.99M | $411.06M | $413.23M | $413.23M |
| 流动资产合计 | $321.30M | $429.22M | $269.40M | $257.13M | $257.13M |
| 现金及现金等价物与短期投资 | $250.48M | $373.64M | $187.18M | $177.21M | $177.21M |
| -现金及现金等价物 | $250.48M | $373.64M | $77.92M | $65.43M | $65.43M |
| -短期投资 | $0.00 | $0.00 | $109.25M | $111.78M | $111.78M |
| 应收款 | $47.73M | $34.38M | $44.59M | $42.63M | $42.63M |
| -应收账款 | $47.73M | $34.38M | $44.59M | $42.63M | $42.63M |
| 存货 | $9.14M | $6.98M | $26.40M | $26.71M | $26.71M |
| 其他流动资产 | $13.94M | $14.23M | $11.23M | $10.59M | $10.59M |
| 非流动资产合计 | $320.16M | $103.77M | $141.67M | $156.10M | $156.10M |
| 固定资产净值 | $50.55M | $43.04M | $54.36M | $55.73M | $55.73M |
| -固定资产原值 | $50.55M | $43.04M | $54.36M | $94.58M | $94.58M |
| 投资及预付款 | $0.00 | $0.00 | $10.90M | $24.17M | $24.17M |
| -持有至到期证券 | $0.00 | – | – | – | – |
| 商誉及其他无形资产 | $261.49M | $54.52M | $72.44M | $72.30M | $72.30M |
| -商誉 | $121.71M | $35.97M | $40.34M | $40.34M | $40.34M |
| -其他无形资产 | $139.78M | $18.56M | $32.10M | $31.96M | $31.96M |
| 其他非流动资产 | $8.12M | $6.20M | $3.97M | $3.90M | $3.90M |
| 负债合计 | $174.00M | $107.39M | $97.53M | $110.13M | $110.13M |
| 流动负债合计 | $138.98M | $93.70M | $79.15M | $89.85M | $89.85M |
| 应付款 | $10.81M | $9.49M | $9.07M | $9.99M | $9.99M |
| -应付账款 | $10.81M | $9.49M | $9.07M | $9.99M | $9.99M |
| 一年内应计费用 | $55.61M | $28.51M | $29.37M | $27.09M | $27.09M |
| 短期债务及融资租赁负债 | $8.69M | $6.05M | $6.66M | $6.52M | $6.52M |
| -一年内到期融资租赁负债 | $8.69M | $6.05M | $6.66M | $6.52M | $6.52M |
| 一年内预提费用 | $16.37M | $9.53M | $7.95M | $3.50M | $3.50M |
| 一年内递延负债 | $6.95M | $5.55M | $5.56M | $4.65M | $4.65M |
| 非流动负债合计 | $35.03M | $13.69M | $18.37M | $20.28M | $20.28M |
| 长期债务及融资租赁负债 | $20.32M | $13.20M | $17.84M | $19.68M | $19.68M |
| -长期融资租赁负债 | $20.32M | $13.20M | $17.84M | $19.68M | $19.68M |
| 一年以上递延负债 | $536,000.00 | $86,000.00 | $130,000.00 | $181,000.00 | $181,000.00 |
| 其他非流动负债 | $14.17M | $406,000.00 | $407,000.00 | $418,000.00 | $418,000.00 |
| 股东权益合计 | $467.46M | $425.60M | $313.54M | $303.10M | $303.10M |
| 股东权益 | $467.46M | $425.60M | $313.54M | $303.10M | $303.10M |
| 股本 | $52,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| -普通股 | $52,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $953.56M | $930.99M | $1.05B | $1.04B | $1.04B |
| 留存收益 | -$486.15M | -$505.45M | -$732.55M | -$735.36M | -$735.36M |
| 不影响留存收益的损益 | $0.00 | $0.00 | -$6.27M | -$5.52M | -$5.52M |
| -累计折旧 | – | – | – | -$38.85M | -$38.85M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $12.72M | $30.60M | $4.33M | $42.03M | $21.36M |
| 持续经营经营活动现金流净额 | $12.72M | $30.60M | $4.33M | $42.03M | $21.36M |
| 持续经营净利润 | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| 持续经营损益 | $0.00 | -$112.88M | $119,000.00 | $48,000.00 | – |
| 折旧、折耗与摊销 | $9.07M | $4.05M | $5.32M | $20.42M | $5.26M |
| 其他非现金项目 | -$9.41M | $51,000.00 | $15,000.00 | $703,000.00 | $108,000.00 |
| 营运资金变动 | -$15.88M | $17.59M | -$14.64M | $3.81M | $12.17M |
| -应收款变动 | -$8.98M | $2.04M | -$2.08M | $22.52M | $5.31M |
| -存货变动 | -$841,000.00 | $2.27M | -$346,000.00 | -$4.96M | $2.03M |
| -预付资产变动 | $1.51M | -$5.50M | -$2.88M | -$4.41M | $3.95M |
| -应付账款及应计费用变动 | -$6.97M | $19.23M | -$7.78M | -$3.35M | $3.37M |
| -其他流动负债变动 | -$2.00M | -$1.40M | -$1.56M | -$6.00M | -$1.54M |
| -其他营运资金变动 | $1.40M | – | – | – | – |
| 投资活动现金流净额 | -$147.88M | $280.59M | $11.06M | $2.16M | -$34.91M |
| 持续经营投资活动现金流净额 | -$147.88M | $280.59M | $11.06M | $2.16M | -$34.91M |
| 资本支出 | -$1.62M | – | – | -$5.91M | -$1.97M |
| 业务购买及出售净额 | -$145.77M | – | – | $0.00 | $0.00 |
| 投资购置及出售净额 | -$500,000.00 | $117.65M | $14.88M | $8.75M | -$32.94M |
| 筹资活动现金流 | $12.90M | -$15.50M | -$2.91M | -$93.39M | -$12.46M |
| 持续经营筹资活动现金流净额 | $12.90M | -$15.50M | -$2.91M | -$93.39M | -$12.46M |
| 普通股发行净额 | $0.00 | – | – | -$87.77M | -$12.21M |
| 股票期权行使所得 | $17.47M | $2.75M | $1.10M | $8.00M | $1.41M |
| 其他筹资费用净额 | -$4.57M | -$6.02M | -$4.01M | -$13.62M | -$1.67M |
| 期末现金余额 | $251.89M | $374.16M | $78.47M | $65.98M | $65.98M |
| 现金净变动 | -$122.27M | $295.69M | $12.48M | -$49.20M | -$26.01M |
| 期初现金余额 | $374.16M | $78.47M | $65.98M | $115.27M | $91.99M |
| 汇率变动影响 | $0.00 | -$9,000.00 | $13,000.00 | -$90,000.00 | $6,000.00 |
| 自由现金流 | $11.10M | $28.75M | $514,000.00 | $35.44M | $19.39M |
| 固定资产购置及出售净额 | – | – | -$3.82M | – | – |
| 递延税款 | – | – | – | $17,000.00 | – |
| 无形资产购置及出售净额 | – | – | – | -$675,000.00 | $0.00 |
暂无评论——快来第一个聊聊 CDNA。
登录后参与讨论。